CONSOLIDATED BALANCE SHEETS - USD ($)	Jul. 31, 2016	Jul. 31, 2015
Current Assets:
Cash and cash equivalents	$ 16,899	$ 749,965
Other current assets	8,077	51,240
Total Current Assets	24,976	801,205
Property and Equipment, Net	1,298	2,869
Patents, Net		1,430,016
TOTAL ASSETS	26,274	2,234,090
Current Liabilities:
Accounts payable and accrued expenses	8,950,870	8,018,333
Loan payable	50,000
Total Current Liabilities	9,000,870	8,018,333
Derivative Warrant Liability	2,048,846	2,363,415
Derivative Additional Investment Rights Liability	193,408	142,662
Total Liabilities	11,243,124	10,524,410
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 2,450,000,000 and 1,500,000,000 shares at April 30, 2016 and July 31, 2015, respectively; 903,333,142 and 825,496,238 issued and outstanding at April 30, 2016 and July 31, 2015, respectively	908,542	825,496
Additional paid-in capital	362,780,108	362,556,710
Accumulated deficit	(375,704,372)	(372,481,263)
Accumulated other comprehensive income	798,872	808,737
Total Stockholders' Deficiency	(11,216,850)	(8,290,320)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	26,274	2,234,090
Series A Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series B Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series C Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series D Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series E Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series F Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series G Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock